Nekvnro Psoriasis

Manufacturer: Guoyu Trading Co., Ltd.
Effective date: 2024-10-23
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 00:30:10

Label at a glance#

ProductNekvnro Psoriasis

Active ingredientSALICYLIC ACID

Label structure12 sections

Dosage and administration

apply twice a day or as needed.

Storage and handling

store at room temperature.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 4%

Purpose

OTC - PURPOSE SECTION

Psoriasis and Seborrheic Dermatitis

Use

INDICATIONS & USAGE SECTION

relieves and helps prevent recurrence of:
■itching

■irritation

■redness

■flaking

■scaling due to psoriasis and seborrheic dermatitis

Do not use

OTC - DO NOT USE SECTION

●on children under 2 years of age unless directedby a doctor

●Avoid contact with eyes.

When Using

OTC - WHEN USING SECTION

this product

■avoid contact with eyes. If contact occurs, rinse thoroughly with water.

Stop Use

OTC - STOP USE SECTION

condition worsens or does not improve after regular use.

Ask Doctor

OTC - ASK DOCTOR SECTION

if condition worsens or does not improve after regular use.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed get medical help or contact a Poison Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

apply twice a day or as needed.

Other information

STORAGE AND HANDLING SECTION

store at room temperature.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Borneol, Cetyl Alcohol, Dimethicone, Glyceryl 1-stearate, Menthol,Nifedipine, etc.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

12345678910

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
2675319	salicylic acid 4 % Topical Cream	PSN	1
2675319	salicylic acid 40 MG/ML Topical Cream	SCD	1
2675319	salicylic acid 4 % Topical Cream	SY	1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bbd94e90-e531-9113-45c1-29860f331640	Product name	7	20230104
5e4d0a9b-8ce4-418c-bf0c-d2b4be281ffd	Product name	4	20220126
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408
308fd2ea-d88a-e021-96c1-7c2ab74d6e4b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
84844-001-01	Nekvnro Psoriasis	100 g in 1 BOTTLE	CREAM	100		1
84844-001-02	Nekvnro Psoriasis	120 g in 1 BOTTLE	CREAM	120		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
84844-001	NEKVNRO PSORIASIS (PSORIASIS) CREAM [GUOYU TRADING CO., LTD.]	1	2 package rows	20241029_25213ad7-dcd6-ae3d-e063-6394a90a9465.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Nekvnro Psoriasis
Psoriasis
DIMETHICONE
MENTHOL
BORNEOL
GLYCERYL 1-STEARATE
NIFEDIPINE
SALICYLIC ACID
CETYL ALCOHOL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
84844-001	84844-001-01, 84844-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
DIMETHICONE	92RU3N3Y1O	IACT
MENTHOL	L7T10EIP3A	IACT
BORNEOL	M89NIB437X	IACT
GLYCERYL 1-STEARATE	258491E1RZ	IACT
NIFEDIPINE	I9ZF7L6G2L	IACT
SALICYLIC ACID	O414PZ4LPZ	ACTIB
CETYL ALCOHOL	936JST6JCN	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
25213ad7-dcd7-ae3d-e063-6394a90a9465			25213ad7-dcd6-ae3d-e063-6394a90a9465	2024-10-23	Warnings	Exact identifier spl id: 25213ad7-dcd7-ae3d-e063-6394a90a9465 spl set id: 25213ad7-dcd6-ae3d-e063-6394a90a9465

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.